T1	Treatment 0 10	Naltrexone
T2	Treatment 55 73	placebo-controlled
T3	Treatment 150 160	naltrexone
T4	Treatment 349 455	Naltrexone, 1.0 mg/kg, was given daily in a randomized, double-blind, placebo-controlled crossover design.
T5	Treatment 456 785	Dependent measures included parent and teacher Clinical Global Impressions (CGI), Conners Rating Scales, and Naltrexone Side-Effects (SE) Rating Scale; laboratory CGI, movement actometer readings, and a 10-second interval recording system analysis of on-task, communication initiations, disruptive behavior, and self-stimulation.
T6	Treatment 1299 1309	Naltrexone
